Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications.

Abbasi A, Johnson TV, Kleris R, Ying K, Bonner MY, Maithel SK, Kooby DA, Marshall FF, Master VA.

J Urol. 2012 Jan;187(1):296-301. doi: 10.1016/j.juro.2011.09.009. Epub 2011 Nov 17.

PMID:
22099996
2.

Re: long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol.

Marshall FF.

J Urol. 2011 Jan;185(1):99-100. doi: 10.1016/S0022-5347(11)60105-5. No abstract available.

PMID:
22082914
3.

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

Johnson TV, Ali S, Abbasi A, Kucuk O, Harris WB, Ogan K, Pattaras J, Nieh PT, Marshall FF, Osunkoya AO, Master VA.

J Urol. 2011 Oct;186(4):1213-7. doi: 10.1016/j.juro.2011.06.014. Epub 2011 Aug 17.

PMID:
21849188
4.

EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.

Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, Nelson PS, Wang YA, Wang R, Shin DM, Marshall FF, Kucuk O, Chung LW, Zhau HE, Wu D.

Oncogene. 2011 Dec 15;30(50):4941-52. doi: 10.1038/onc.2011.199. Epub 2011 May 30.

5.

Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.

Shigemura K, Huang WC, Li X, Zhau HE, Zhu G, Gotoh A, Fujisawa M, Xie J, Marshall FF, Chung LW.

Prostate. 2011 Dec;71(16):1711-22. doi: 10.1002/pros.21388. Epub 2011 Apr 25.

6.

Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.

Zhau HE, He H, Wang CY, Zayzafoon M, Morrissey C, Vessella RL, Marshall FF, Chung LW, Wang R.

Clin Cancer Res. 2011 Apr 15;17(8):2159-69. doi: 10.1158/1078-0432.CCR-10-2523. Epub 2011 Feb 25.

7.

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.

Ali S, Yin-Goen Q, Johnson TV, Han W, Johnson NA, Harris WB, Marshall FF, Young AN, Master VA, Osunkoya AO.

Tumour Biol. 2011 Apr;32(2):375-80. doi: 10.1007/s13277-010-0130-9. Epub 2010 Nov 18.

PMID:
21086092
8.

Urological oncology: renal, ureteral and retroperitoneal tumors.

Marshall FF.

J Urol. 2010 Nov;184(5):1926-7. doi: 10.1016/j.juro.2010.07.042. Epub 2010 Sep 18. No abstract available.

PMID:
22519995
9.

Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans.

Abd TT, Goodman M, Hall J, Ritenour CW, Petros JA, Marshall FF, Issa MM.

Urology. 2011 Mar;77(3):541-7. doi: 10.1016/j.urology.2010.06.008.

PMID:
20817273
10.

Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young AN, Kucuk O, Harris WB, Osunkoya AO, Ogan K, Pattaras J, Nieh PT, Marshall FF, Master VA.

Urology. 2010 Sep;76(3):766.e1-5. doi: 10.1016/j.urology.2010.01.052. Epub 2010 Apr 14.

PMID:
20394975
11.

Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.

Sun X, He H, Xie Z, Qian W, Zhau HE, Chung LW, Marshall FF, Wang R.

In Vitro Cell Dev Biol Anim. 2010 Jun;46(6):538-46. doi: 10.1007/s11626-010-9309-z. Epub 2010 Apr 10.

12.

XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.

Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA.

Urology. 2010 Apr;75(4):755-61. doi: 10.1016/j.urology.2010.01.038.

PMID:
20371060
13.

Impact of laparoscopic inguinal hernia repair mesh on open radical retropubic prostatectomy.

Saint-Elie DT, Marshall FF.

Urology. 2010 Nov;76(5):1078-82. doi: 10.1016/j.urology.2010.01.015. Epub 2010 Apr 3.

PMID:
20363494
14.

Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells.

He H, Davidson AJ, Wu D, Marshall FF, Chung LW, Zhau HE, He D, Wang R.

Prostate. 2010 Jul 1;70(10):1119-26. doi: 10.1002/pros.21146.

15.

Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.

He H, Xu J, Nelson PS, Marshall FF, Chung LW, Zhau HE, He D, Wang R.

Prostate. 2010 Jun 15;70(9):993-1001. doi: 10.1002/pros.21133.

16.

Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.

Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, Fan S, Chen Z, Wang R, Marshall FF, Chung LW, Wu D.

Mol Cancer. 2010 Jan 19;9:9. doi: 10.1186/1476-4598-9-9.

17.

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young A, Ogan K, Pattaras J, Nieh P, Marshall FF, Master VA.

J Urol. 2010 Feb;183(2):480-5. doi: 10.1016/j.juro.2009.10.014. Epub 2009 Dec 14.

PMID:
20006861
18.

Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.

He H, Yang X, Davidson AJ, Wu D, Marshall FF, Chung LW, Zhau HE, Wang R.

Prostate. 2010 Apr 1;70(5):518-28. doi: 10.1002/pros.21086.

19.

The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.

Ritenour CW, Abbott JT, Goodman M, Alazraki N, Marshall FF, Issa MM.

ScientificWorldJournal. 2009 Oct 2;9:1040-5. doi: 10.1100/tsw.2009.113.

20.

Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans.

Moses KA, Abd TT, Goodman M, Hsiao W, Hall JA, Marshall FF, Petros JA, Issa MM.

J Urol. 2009 Nov;182(5):2219-25. doi: 10.1016/j.juro.2009.07.039. Epub 2009 Sep 16.

PMID:
19758611
21.

Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.

Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF, Chung LW.

Eur Urol. 2010 Jul;58(1):162-71. doi: 10.1016/j.eururo.2009.08.026. Epub 2009 Sep 4.

22.

Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.

Wang R, He H, Sun X, Xu J, Marshall FF, Zhau H, Chung LW, Fu H, He D.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):455-60. doi: 10.1016/j.bbrc.2009.08.165. Epub 2009 Sep 2.

23.
24.

Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.

Shigemura K, Isotani S, Wang R, Fujisawa M, Gotoh A, Marshall FF, Zhau HE, Chung LW.

Prostate. 2009 Jun 15;69(9):949-55. doi: 10.1002/pros.20944.

25.

Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

Sung SY, Hsieh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL, Nelson P, Lee JK, Amin MB, Lyles R, Johnstone PA, Marshall FF, Chung LW.

Cancer Res. 2008 Dec 1;68(23):9996-10003. doi: 10.1158/0008-5472.CAN-08-2492.

26.

Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter?

Jessie BC, Marshall FF.

Int J Urol. 2008 Oct;15(11):951-6. doi: 10.1111/j.1442-2042.2008.02155.x. Epub 2008 Sep 2. Review.

27.

Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.

Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW.

Cell Res. 2008 Aug;18(8):858-70. doi: 10.1038/cr.2008.84.

PMID:
18645583
28.

The behavior of renal cell carcinoma: sex, lies and tumor size.

Marshall FF.

J Urol. 2008 May;179(5):1657. doi: 10.1016/j.juro.2008.02.003. Epub 2008 Mar 17. No abstract available.

PMID:
18343448
29.

Quantum dots: emerging applications in urologic oncology.

Shi C, Zhu Y, Cerwinka WH, Zhau HE, Marshall FF, Simons JW, Nie S, Chung LW.

Urol Oncol. 2008 Jan-Feb;26(1):86-92. doi: 10.1016/j.urolonc.2007.03.018. Review.

PMID:
18190836
30.

PrLZ is expressed in normal prostate development and in human prostate cancer progression.

Wang R, Xu J, Mabjeesh N, Zhu G, Zhou J, Amin M, He D, Marshall FF, Zhau HE, Chung LW.

Clin Cancer Res. 2007 Oct 15;13(20):6040-8.

31.

cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis.

Wu D, Zhau HE, Huang WC, Iqbal S, Habib FK, Sartor O, Cvitanovic L, Marshall FF, Xu Z, Chung LW.

Oncogene. 2007 Aug 2;26(35):5070-7. Epub 2007 Feb 19.

PMID:
17310988
32.

Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis.

Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H, Zayzafoon M, Young AN, Marshall FF, Weitzmann MN, Chung LW.

Clin Cancer Res. 2006 Dec 15;12(24):7294-305.

33.

Surgery in advanced and metastatic renal cell carcinoma.

Chan DY, Marshall FF.

Curr Opin Urol. 1998 Sep;8(5):369-73.

PMID:
17039014
34.

Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.

Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, Anderson C, Johnstone P, Petros JA, Marshall FF, Zhau HE, Chung LW.

Cancer Res. 2006 Oct 1;66(19):9519-26.

35.

Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.

Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA.

Cancer Res. 2006 Sep 1;66(17):8542-9.

36.

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

Healy KA, Marshall FF, Ogan K.

Expert Rev Anticancer Ther. 2006 Aug;6(8):1295-304. Review.

PMID:
16925495
37.

The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.

Issa MM, Zasada W, Ward K, Hall JA, Petros JA, Ritenour CW, Goodman M, Kleinbaum D, Mandel J, Marshall FF.

Cancer Detect Prev. 2006;30(3):269-75. Epub 2006 Jul 17.

PMID:
16844319
38.

Current trends in molecular classification of adult renal tumors.

Young AN, Dale J, Yin-Goen Q, Harris WB, Petros JA, Datta MW, Wang MD, Marshall FF, Amin MB.

Urology. 2006 May;67(5):873-80. Review. No abstract available.

PMID:
16698345
39.

Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor.

Pflug BR, Zheng H, Udan MS, D'Antonio JM, Marshall FF, Brooks JD, Nelson JB.

Cancer Lett. 2007 Feb 8;246(1-2):139-48. Epub 2006 Apr 3.

PMID:
16581180
40.

Percutaneous cryoablation of renal tumors: limitations and uncertainties.

Pattaras JG, Marshall FF.

Nat Clin Pract Urol. 2005 Nov;2(11):518-9. No abstract available.

PMID:
16474579
41.

North American white mitochondrial haplogroups in prostate and renal cancer.

Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, Lim SD, Fernandez-Golarz C, Lyles RH, Brown MD, Marshall FF, Petros JA.

J Urol. 2006 Feb;175(2):468-72; discussion 472-3.

PMID:
16406974
42.

Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.

Marshall FF.

J Urol. 2005 Nov;174(5):1782. No abstract available.

PMID:
16217284
44.

Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases.

Marshall FF.

J Urol. 2005 Oct;174(4 Pt 1):1249. No abstract available.

PMID:
16145381
45.

Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.

Issa MM, Lendvay TS, Bouet R, Young MR, Petros JA, Marshall FF.

J Urol. 2005 Sep;174(3):893-7.

PMID:
16093982
46.

A renal mass in the setting of a nonrenal malignancy. When is a renal tumor biopsy appropriate?

Marshall FF.

J Urol. 2005 Sep;174(3):868. No abstract available.

PMID:
16093974
47.

Promoter hypermethylation profile of kidney cancer.

Marshall FF.

J Urol. 2005 Aug;174(2):484-5. No abstract available.

PMID:
16006871
48.

The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.

Marshall FF.

J Urol. 2005 Aug;174(2):483-4. No abstract available.

PMID:
16006869
50.

Supplemental Content

Loading ...
Support Center